News

MARINA DEL REY, Calif., Oct. 15, 2020 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ('Armata' or the 'Company'), a biotechnol ...
Armata Pharmaceuticals Logo (PRNewsfoto/Armata Pharmaceuticals, Inc.) The publication, titled, "Cryo-EM analysis of Pseudomonas phage Pa193 structural components," describes the structure of phage ...
Armata Pharmaceuticals Logo (PRNewsfoto/Armata Pharmaceuticals, Inc.) Proceeds from the new financing transaction will be used to advance the Company's lead therapeutic phage candidates, including ...
MARINA DEL REY, Calif., Oct. 16, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted ...